Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer

Table 2

Outcome related to HER2 overexpression.

	HER2 −	HER2+	𝑃 value
Number (%)	65 (76)	20 (24)
Median age (years)	66	69	0.705
Gender M : F (%)	48 : 17 (74 : 26)	16 : 4 (80 : 20)	0.577
pTNM (%)
I and II	(52)	(40)	0.089
III and IV	(48)	(60)
Morbidity (%)	23 (35)	7 (35)	0.975
Mortality (%)	2 (3)	1 (5)	0.47
Median survival (months)	43	27	0.221
1 year survival (%)	89	80
2 year survival (%)	61	55
5 year survival (%)	43	30